Last Updated: Apr 07, 2016
- UK BRCA mutation testing in patients with ovarian cancer.
George Angela et al. British journal of cancer 2015 Dec 113 Suppl 1S17-21 - Family history predictors of BRCA1/BRCA2 mutation status among Tunisian breast/ovarian cancer families.
Riahi Aouatef et al. Breast cancer (Tokyo, Japan) 2016 Mar - BRCA testing, treatment patterns and survival in platinum-sensitive recurrent ovarian cancer - an observational cohort study.
Unni Sudhir K et al. Journal of ovarian research 2016 9(1) 18 - Molecular insights into the OGG1 gene, a cancer risk modifier in BRCA1 and BRCA2 mutations carriers.
Benitez-Buelga Carlos, et al. Oncotarget 2016 3 - Randomized phase II trial of cyclophosphamide and the oral poly (ADP-ribose) polymerase inhibitor veliparib in patients with recurrent, advanced triple-negative breast cancer.
Kummar Shivaani, et al. Investigational new drugs 2016 3 - Beyond BRCA: Lynch Syndrome
My gene counsel, March 22, 2016 - Non-Neoplastic Conditions of the Ovaries in Grossly Normal Adnexa: A Clinicopathologic Study of 403 Completely Embedded Cases.
Seidman Jeffrey D, et al. International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 2016 3 - Bad Luck Or Bad Genes? Dealing With BRCA And 'A Cancer In The Family',
NPR, March 14, 2016 - Eligibility Criteria and Genetic Testing Results from a High-Risk Cohort for Hereditary Breast and Ovarian Cancer Syndrome in Southeastern Ontario.
Vidal Ricardo Dos Santos et al. The Journal of molecular diagnostics : JMD 2016 Feb - FORCE family letter for BRCA1 and BRCA2 carriers
Disease: Breast Cancer|Ovarian Cancer; Type: Tools; State: Multiple States - Adding In Silico Assessment of Potential Splice Aberration to the Integrated Evaluation of BRCA Gene Unclassified Variants.
Vallée Maxime P, et al. Human mutation 2016 2 - Contribution of mammography to MRI screening in BRCA mutation carriers by BRCA status and age: individual patient data meta-analysis.
Phi Xuan-Anh, et al. British journal of cancer 2016 2 - Prioritizing Variants in Complete Hereditary Breast and Ovarian Cancer (HBOC) Genes in Patients Lacking known BRCA Mutations.
Caminsky Natasha G, et al. Human mutation 2016 2 - Low prevalence of HER2 positivity amongst BRCA1 and BRCA2 mutation carriers and in primary BRCA screens.
Evans D G, et al. Breast cancer research and treatment 2016 2 (3) 597-601 - Talking about BRCA in your family tree
Disease: Breast Cancer|Ovarian Cancer; Type: Tools; State: Multiple States - FORCE Letter to Relatives about Genetic Mutation
Disease: Breast Cancer|Ovarian Cancer; Type: Tools; State: Multiple States - Cancerous leptomeningitis and familial congenital hypopituitarism.
Vujovic S, et al. Endocrine 2016 2 - Twenty-one-gene recurrence score assay in BRCA-associated versus sporadic breast cancers: Differences based on germline mutation status.
Shah Payal D, et al. Cancer 2016 2 - More than 'Angelina Jolie Effect': BRCA tests spike among breast cancer patients
Hutch News, February 11,2016 - Tracking of the origin of recurrent mutations of the BRCA1 and BRCA2 genes in the North-East of Italy and improved mutation analysis strategy.
Cini Giulia, et al. BMC medical genetics 2016 0 (1) 11 - Increased Reach of Genetic Cancer Risk Assessment as a Tool for Precision Management of Hereditary Breast Cancer
KR Blazer et al, JAMA Oncology, February 11, 2016 - BRCA1 and BRCA2 Mutation Testing in Young Women With Breast Cancer
SM Rosenberg et al, JAMA Oncology, February 11, 2016 - Health Buzz: More Young Women With Breast Cancer Seeking Genetic Testing, Study Finds
Knowing BRCA status helps women make better-informed treatment decisions, L Esposito, US Health News, February 11, 2016 - Prevalence and spectrum of BRCA germline variants in mainland Chinese familial breast and ovarian cancer patients.
Kim Yeong C, et al. Oncotarget 2016 2 - Risk-reducing surgery on the uterine adnexa: timing and type of surgical treatment and pathology report.
Mauro Signorelli, et al. Minerva ginecologica 2016 2 - Impact of Socioeconomic Status and Ethnicity on Melanoma Presentation and Recurrence in Caucasian Patients.
Salvaggio Christine, et al. Oncology 2016 2 (2) - BRCA1/BRCA2 founder mutations and cancer risks: impact in the western Danish population.
Nielsen Henriette Roed, et al. Familial cancer 2016 2 - Ovarian cancer patients at high risk of BRCA mutation: the constitutional genetic characterization does not change prognosis.
Sabatier Renaud, et al. Familial cancer 2016 2 - Multiple gene sequencing for risk assessment in patients with early-onset or familial breast cancer.
Lin Po-Han, et al. Oncotarget 2016 1 - Phase I Study of Veliparib (ABT-888) Combined with Cisplatin and Vinorelbine in Advanced Triple-Negative Breast Cancer and/or BRCA Mutation-Associated Breast Cancer.
Rodler Eve T, et al. Clinical cancer research : an official journal of the American Association for Cancer Research 2016 1
- Hot Topics (30)
- Genomics & Health Impact Scan (0)
- AMD Weekly Clips (0)
- HuGE (448)
- AMD Weekly Clips (0)
- Weekly Scan (120)
- AMD Weekly Clips (0)
.png)
No hay comentarios:
Publicar un comentario